Psychiatry/Behavioral · PANCE / PANRE

Antisocial Personality Disorder (ASPD)

Pervasive disregard for and violation of the rights of others since age 15, with conduct disorder before age 15.

Also known as: ASPD, antisocial personality disorder, sociopathy

Overview

A Cluster B personality disorder marked by a pervasive pattern of disregard for and violation of the rights of others since age 15, diagnosed in individuals >=18 with evidence of conduct disorder onset before age 15.

Epidemiology

Lifetime prevalence ~1-4%; substantially higher in incarcerated populations (~40-70%). Male predominance ~3:1. Onset childhood/adolescence with often attenuating antisocial acts by mid-life, though core traits persist.

🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Antisocial Personality Disorder (ASPD) outline — plus all 514 diagnoses, 3,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Free to start · No credit card · Cancel anytime

Risk factors

  • Conduct disorder before age 15 (required for diagnosis)
  • Childhood maltreatment, neglect, inconsistent discipline
  • Family history of ASPD or substance use disorders
  • Lower socioeconomic status, exposure to community violence
  • Comorbid ADHD in childhood
  • Substance use disorders

Pathophysiology

Heritable callous-unemotional traits with reduced amygdala reactivity to distress cues, impaired fear conditioning, and prefrontal dysfunction. Low resting heart rate and reduced autonomic reactivity in childhood are early markers.

Clinical presentation

Symptoms

  • >=3 of 7 criteria since age 15: failure to conform to social/legal norms (arrests); deceitfulness (lying, conning); impulsivity; irritability and aggressiveness (fights, assaults); reckless disregard for safety of self/others; consistent irresponsibility (work, finances); lack of remorse
  • Conduct disorder onset before age 15 (aggression to people/animals, destruction of property, deceitfulness/theft, serious rule violations)

Signs / physical exam

  • Charm without empathy; superficial affect
  • Forensic history, tattoos in some cultural contexts (not diagnostic)
  • Substance use comorbidity is the rule, not exception

Differential diagnosis

  • Substance use disorder alone — Antisocial behavior limited to acquiring/using substances; pattern remits with abstinence
  • Narcissistic personality disorder — Grandiosity and need for admiration without aggression or law-breaking
  • Borderline personality disorder — Self-directed harm and identity disturbance predominate; less predatory
  • Intermittent explosive disorder — Discrete aggressive outbursts disproportionate to provocation; otherwise normal interpersonal functioning
  • Conduct disorder — Same behavioral profile in <18 years old; ASPD requires >=18
  • Adult ADHD — Impulsivity without callousness or deceit

Diagnostic workup

Diagnostic criteria

DSM-5-TR: (A) >=3 of 7 antisocial criteria since age 15; (B) >=18 years old; (C) Conduct disorder with onset before age 15; (D) Antisocial behavior not exclusively during schizophrenia or bipolar episodes. Psychopathy Checklist-Revised (PCL-R) measures related but narrower construct of psychopathy.

Labs

  • Urine drug screen, breath alcohol
  • Hepatitis B/C, HIV given high prevalence in this population
  • Routine medical labs as indicated

Imaging

  • Not routinely indicated

Diagnostic algorithm

Cluster B comparisonCore featureAffectSelf-harm
AntisocialViolation of others' rightsShallow, low remorseUncommon
BorderlineInstability + abandonment fearIntense, reactiveCommon
NarcissisticGrandiosity, need for admirationFragile self-esteemUncommon
HistrionicAttention-seeking, theatricalShallow, shiftingUncommon
Cluster B personality disorders — distinguishing features.

Treatment

First-line

  • Treat comorbid substance use disorder — often the most modifiable contributor to behavior
  • Treat comorbid depression, anxiety, and ADHD; avoid stimulants and benzodiazepines when possible
  • Cognitive behavioral interventions in structured settings (e.g., correctional programs) show modest effect on recidivism
  • Contingency management; supervised community programs
  • Safety planning for clinicians; clear limits

Second-line / adjunct

  • No FDA-approved pharmacotherapy for ASPD itself
  • Mood stabilizers or atypical antipsychotics may reduce aggression
  • Family/partner support and child protective involvement when relevant
  • Recognize limits of intervention with patients who do not perceive a problem

Complications

  • Premature mortality from violence, accidents, suicide, substance use
  • Incarceration, unemployment, family disruption
  • Substance use disorders, comorbid ADHD
  • Victimization of family members and intimate partners
  • Iatrogenic harm from manipulation of healthcare systems for opioids/benzodiazepines

PANCE pearls

  • Childhood conduct disorder is required — without evidence of pre-15 antisocial behavior, the diagnosis cannot be made.
  • Antisocial behavior limited to substance acquisition does NOT establish ASPD; reassess after sustained abstinence.
  • Psychopathy (PCL-R) is a narrower construct emphasizing callous-unemotional traits and predicts violence risk better than ASPD diagnosis alone.
  • Maintain clear boundaries and avoid prescribing controlled substances; document carefully.

References

  • NICE CG77 — NICE Clinical Guideline 77: Antisocial personality disorder: prevention and management
  • DSM-5-TR — American Psychiatric Association. DSM-5-TR (2022)
  • Hare PCL-R — Hare RD. The Hare Psychopathy Checklist-Revised, 2nd ed. (2003)

Practice Psychiatry/Behavioral questions on FirstPassPA

Turn this outline into retention. 3,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Start studying free → Browse all 514 diagnoses

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants.